SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001539497-24-000104
Filing Date
2024-01-24
Accepted
2024-01-24 16:00:27
Documents
14
Period of Report
2024-01-24
Items
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K n3936_x2-8k.htm   iXBRL 8-K 41874
2 CERTIFICATE OF DESIGNATION OF SENIOR A JUNIOR PREFERRED STOCK OF BELLICUM PHARMA exh3-1.htm EX-3.1 15311
3 AMENDMENT TO AMENDED AND RESTATED BYLAWS OF BELLICUM PHARMACEUTICALS, INC., EFFE exh3-2.htm EX-3.2 5544
  Complete submission text file 0001539497-24-000104.txt   244407

Data Files

Seq Description Document Type Size
4 XBRL SCHEMA FILE blcm-20240124.xsd EX-101.SCH 3015
5 XBRL LABEL FILE blcm-20240124_lab.xml EX-101.LAB 34240
6 XBRL PRESENTATION FILE blcm-20240124_pre.xml EX-101.PRE 22359
8 EXTRACTED XBRL INSTANCE DOCUMENT n3936_x2-8k_htm.xml XML 4402
Mailing Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098
Business Address 3730 KIRBY DRIVE SUITE 1200 HOUSTON TX 77098 (832) 384-1100
BELLICUM PHARMACEUTICALS, INC (Filer) CIK: 0001358403 (see all company filings)

IRS No.: 201450200 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36783 | Film No.: 24556375
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)